ELAN PHARMACEUTICAL INVESTMENTS LTD 4
4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Apr 15, 2004
Insider Transaction Report
Form 4
ELAN CORP PLC
10% Owner
Transactions
- Sale
Common Stock
2004-04-13$3.00/sh−2,500$7,500→ 2,439,936 total(indirect: I)
Footnotes (1)
- [F1]The securities are beneficially owned indirectly by Elan Corporation, plc and directly by its wholly-owned subsidiary, Elan International Services, Ltd.